Meeting
2015 Gastrointestinal Cancers Symposium
Interleukin-6 (IL-6) as an inflammatory biomarker in patients with hepatobiliary cancers.
Authors
Sidra Anwar
State University of New York at Buffalo, Buffalo, NY
Sidra Anwar , Austin Miller , Gerald J. Fetterly , Renuka V. Iyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 257)
DOI
10.1200/jco.2015.33.3_suppl.257
Abstract #
257
Poster Bd #
A28
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Overall survival modeling and association with serum biomarkers in durvalumab-treated patients with head and neck cancer.
First Author: Vadryn Pierre
Poster
2018 Gastrointestinal Cancers Symposium
Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer.
First Author: Inna Chen
Poster
2016 Gastrointestinal Cancers Symposium
Possible role of the systemic inflammatory reaction in defining tumor responder vs. nonresponder in cancer macrobead therapy.
First Author: Barry H. Smith
Poster
2013 Gastrointestinal Cancers Symposium
Microenvironment and cytokines in pseudomyxoma peritonei.
First Author: Kush Lohani